electroCore (ECOR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
9 Sep, 2026Opening remarks and agenda
Chairman welcomed attendees and introduced directors, officers, legal counsel, auditors, and election inspector.
Provided instructions for technical support and outlined the meeting agenda, including voting procedures.
Board and executive committee updates
Introduced current board members and executive officers, including interim President/CFO and COO.
Shareholder proposals
No shareholder proposals were received by the required deadline; none were considered at the meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from electroCore
- H1 revenue grew 35%, with FY26 growth guidance raised above 30%.ECOR
Corporate presentation - Record Q3 sales and lower losses contrast with substantial 12-month funding uncertainty.ECORQ3 2026
- Federal-market expansion and Quell’s pipeline support a 2H2027 adjusted EBITDA target.ECORPlanet MicroCap Showcase: Toronto 2026
- Bioelectronic medicine firm posts strong revenue growth and expands FDA-cleared product reach.ECORCorporate presentation
- Q2 2026 sales up 28%, net loss narrows, but cash burn raises going concern risks.ECORQ2 2026
- Board recommends voting for directors, auditor ratification, and executive pay at the 2026 virtual meeting.ECORProxy filing
- Q3 revenue up 45% year-over-year, net loss narrows, and cash position strengthens.ECORQ3 2024
- Q2 sales hit $6.1M, margin rose to 86%, and $9M was raised, led by VA/DoD and Truvaga growth.ECORQ2 2024
- Q1 2025 revenue up 23% to $6.7M; NeuroMetrix acquired; gross margin 85%; $30M FY outlook.ECORQ1 2025